Correlation Between Medpace Holdings and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Medpace Holdings and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medpace Holdings and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medpace Holdings and Molecular Partners AG, you can compare the effects of market volatilities on Medpace Holdings and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medpace Holdings with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medpace Holdings and Molecular Partners.
Diversification Opportunities for Medpace Holdings and Molecular Partners
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Medpace and Molecular is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Medpace Holdings and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Medpace Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medpace Holdings are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Medpace Holdings i.e., Medpace Holdings and Molecular Partners go up and down completely randomly.
Pair Corralation between Medpace Holdings and Molecular Partners
Given the investment horizon of 90 days Medpace Holdings is expected to generate 1.86 times less return on investment than Molecular Partners. But when comparing it to its historical volatility, Medpace Holdings is 1.65 times less risky than Molecular Partners. It trades about 0.08 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 525.00 in Molecular Partners AG on September 15, 2024 and sell it today you would earn a total of 30.00 from holding Molecular Partners AG or generate 5.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Medpace Holdings vs. Molecular Partners AG
Performance |
| Timeline |
| Medpace Holdings |
| Molecular Partners |
Medpace Holdings and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medpace Holdings and Molecular Partners
The main advantage of trading using opposite Medpace Holdings and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medpace Holdings position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Medpace Holdings vs. Molecular Partners AG | Medpace Holdings vs. MediciNova | Medpace Holdings vs. Anebulo Pharmaceuticals | Medpace Holdings vs. Shattuck Labs |
| Molecular Partners vs. Puma Biotechnology | Molecular Partners vs. Iovance Biotherapeutics | Molecular Partners vs. Day One Biopharmaceuticals | Molecular Partners vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |